Recent indications that the Trump administration is seeking to slash approximately $5.8 billion from the National Institutes of Health budget has touched off debate about public versus private medical research and the impact those budget cuts could have on the development of new therapies and medicines to treat patients.

In the weeks leading up to the collapse of the American Health Care Act, health policy expert Joseph Antos warned Republicans to take their time and improve of some of the provisions in the bill.

The American Enterprise Institute recently published an article examining the e-cigarette industry, particularly striving to determine whether the haze surrounding public perception of the business is as pervasive as it was one year ago.

House Speaker Paul Ryan recently laid out a health care plan that would serve as a Republican alternative to Obamacare, leaving some of the health care law’s current provisions in place and replacing the less popular ones.

As the rate of business startup activity in the United States flatlines, changes in national health policy, among others, could help turn around the situation, an American Enterprise Institute (AEI) expert said last week.